1-4 of 4
Richard Herrmann, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.

Andreas Engert, MD, Volker Diehl, MD, Emeritus, Annette Pluetschow, Hans T. Eich, Richard Herrmann, MD, Bernd Doerken, Lothar Kanz, MD, Richard Greil, Jana Markova, Michael Fuchs, Peter Borchmann, PD, Dr., Hans Konrad Mueller-Hermelink, Rolf Peter Mueller
Journal: Blood
Blood (2009) 114 (22): 716.
https://doi.org/10.1182/blood.V114.22.716.716
Published: 2009
Journal Articles

Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Peter Borchmann, Volker Diehl, Helen Goergen, Horst Mueller, Rolf Peter Mueller, Hans T. Eich, Hans Konrad Mueller-Hermelink, Richard Herrmann, MD, Jana Markova, Anthony D. Ho, MD, PhD, Wolfgang Hiddemann, Bernd Doerken, Richard Greil, Andreas Engert, MD
Journal: Blood
Blood (2009) 114 (22): 717.
https://doi.org/10.1182/blood.V114.22.717.717
Published: 2009
Journal Articles

Radioimmunotherapy (RIT) with 177 Lutetium-DOTA-Rituximab ( 177 LU-D- R): A Phase I/II - Study in 30 Patients with Relapsing Follicular, Mantle Cell and Other Indolent B-Cell Lymphomas

Andreas Lohri, MD, Flavio Forrer, MD, PhD, Benedetta Campana, Christoph Mamot, MD, Ralph Winterhalder, MD, Richard Herrmann, MD, Helmuth R Maecke, PhD, Jan Mùˆller-Brand, MD
Journal: Blood
Blood (2008) 112 (11): 3055.
https://doi.org/10.1182/blood.V112.11.3055.3055
Published: 2008
Journal Articles

Pamidronate Therapy for One Year after Allogeneic Bone Marrow Transplantation (AlloBMT) Reduces Bone Loss from the Lumbar Spine, Femoral Neck and Total Hip.

Andrew C. Grigg, MD, Peter Shuttleworth, RN, John Reynolds, PhD, Jeff Szer, MD, Anthony P. Schwarer, MD, Andrew W. Roberts, MD, Ken F. Bradstock, MD, Chi-Hung Hui, MD, Richard Herrmann, MD, Peter Ebeling, MD
Journal: Blood
Blood (2004) 104 (11): 2253.
https://doi.org/10.1182/blood.V104.11.2253.2253
Published: 2004